Market Cap: $41.8B
Market Cap: $41.8B
Open
$88.60
Prev. Close
$99.14
High
$88.60
Low
$86.86
Operating globally, Sandoz Group AG specializes in the development, production, and distribution of generic medications and biosimilar products. The company's portfolio includes the creation and sale of finished dosage forms for small molecule pharmaceuticals, often supplied to other entities.
Sandoz Group AG trades on the Other OTC under the ticker SDZNY, priced in USD.
Sandoz Group AG has a market capitalisation of $41.8B, based on its latest share price.
SDZNY trades at 66.32 times its trailing 12-month earnings.
Over the past 52 weeks SDZNY has traded between $65.81 and $103.98.
Yes. Sandoz Group AG's dividend yields 0.96% at the current share price, paying out 67% of its earnings.
Profitable, with a net margin of 5.6% over the last 12 months.
The analyst consensus rating for SDZNY is Hold.
Richard Saynor is the CEO of Sandoz Group AG, which is headquartered in Basel.
Generated automatically from reported financial data. General information only, not financial advice.